Abstract
Anthrax is an infection caused by the spore-forming bacterium, Bacillus anthracis. Infection occurs in mammals, particularly herbivores that ingest bacterial spores from soil. Human infection occurs from inhalation of spores, ingestion of animal meat contaminated with spores, or percutaneous inoculation of spores from exposure to infected animals or contaminated animal products. Anthrax has been an occupational disease of textile workers, farmers, butchers, veterinarians, and shepherds.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Turnbull PCB. Introduction: anthrax history, disease and ecology. Curr Top Microbiol Immunol. 2002;271:1–19.
Grabenstein JD. Anthrax vaccine: a review. Immunol Allergy Clin North Am. 2003;23:713–30.
Irmak H, Buzgan T, Karahocagil MK, et al. Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases. Acta Med Okayama. 2003;57:235–40.
Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med. 1999;341:815–26.
Watson A, Keir D. Information on which to base assessments of risk from environments contaminated with anthrax spores. Epidemiol Infect. 1994;113:479–90.
Chensue SW. Exposing a killer: pathologists angle for anthrax. Am J Pathol. 2003;163:1699–702.
Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol. 2004;7:19–24.
Brook I. The prophylaxis and treatment of anthrax. Int J Antimicrob Agents. 2002;20:320–5.
Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202–8.
Inglesby TV, O’Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236–52.
Cinti SK, Saravolatz L, Nafziger D, Sunstrum J, Blackburn G. Differentiating inhalational anthrax from other influenzalike illnesses in the setting of a national or regional anthrax outbreak. Arch Intern Med. 2004;164:674–6.
Stephenson J. Rapid anthrax test approved. JAMA. 2004;292:30.
http://www.immunetics.com/anthrax.html. Accessed 5/28/15.
Kim J, Gedi V, Cho JH, Moon JY, Yoon MY. Advances in anthrax detection: overview of bioprobes and biosensors. Appl Biochem Biotechnol. 2015;176:957–77. doi:10.1007/s12010-015-1625-z.
Lebowich RJ, McKillip BG, Conboy JR. Cutaneous anthrax: a pathologic study with clinical correlation. Am J Clin Pathol. 1943;13:505–15.
Mallon E, McKee PH. Extraordinary case report: cutaneous anthrax. Am J Dermatopathol. 1997;19:79–82.
http://www.cdc.gov/anthrax/. Accessed 5/28/15.
Kaya A, Tasyaran MA, Erol S, Ozkurt Z, Ozkan B. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis. 2002;21:258–61.
Hendricks KA, Wright ME, Shadomy SV, et al. Center for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20(2):e130687. doi:10.3201/eid2002.130687.
Bast DJ, Athamna A, Duncan CL, et al. Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance. J Antimicrob Chemother. 2004;54:90–4.
Krishnan V, Anderson BH, Shoemaker C, et al. Efficacy and immunogenicity of a single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine Absorbed in an aerosolized spore rabbit challenge model. Clin Vaccine Immunol. 2015;22(4):430–9. doi:10.1128/CVI.00690-14. Epub 2015 Feb 11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Somach, S.C. (2016). Anthrax. In: Crowe, D., Morgan, M., Somach, S., Trapp, K. (eds) Deadly Dermatologic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-31566-9_29
Download citation
DOI: https://doi.org/10.1007/978-3-319-31566-9_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31564-5
Online ISBN: 978-3-319-31566-9
eBook Packages: MedicineMedicine (R0)